1. Home
  2. CADL vs MGPI Comparison

CADL vs MGPI Comparison

Compare CADL & MGPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CADL
  • MGPI
  • Stock Information
  • Founded
  • CADL 1999
  • MGPI 1941
  • Country
  • CADL United States
  • MGPI United States
  • Employees
  • CADL N/A
  • MGPI N/A
  • Industry
  • CADL Biotechnology: Pharmaceutical Preparations
  • MGPI Beverages (Production/Distribution)
  • Sector
  • CADL Health Care
  • MGPI Consumer Staples
  • Exchange
  • CADL Nasdaq
  • MGPI Nasdaq
  • Market Cap
  • CADL 185.2M
  • MGPI N/A
  • IPO Year
  • CADL 2021
  • MGPI 1988
  • Fundamental
  • Price
  • CADL $6.20
  • MGPI $79.75
  • Analyst Decision
  • CADL Strong Buy
  • MGPI Strong Buy
  • Analyst Count
  • CADL 1
  • MGPI 3
  • Target Price
  • CADL $11.00
  • MGPI $117.33
  • AVG Volume (30 Days)
  • CADL 604.7K
  • MGPI 191.0K
  • Earning Date
  • CADL 08-08-2024
  • MGPI 08-01-2024
  • Dividend Yield
  • CADL N/A
  • MGPI 0.60%
  • EPS Growth
  • CADL N/A
  • MGPI N/A
  • EPS
  • CADL N/A
  • MGPI 4.33
  • Revenue
  • CADL N/A
  • MGPI $806,076,000.00
  • Revenue This Year
  • CADL N/A
  • MGPI N/A
  • Revenue Next Year
  • CADL N/A
  • MGPI $5.44
  • P/E Ratio
  • CADL N/A
  • MGPI $18.43
  • Revenue Growth
  • CADL N/A
  • MGPI 2.28
  • 52 Week Low
  • CADL $0.66
  • MGPI $68.86
  • 52 Week High
  • CADL $14.30
  • MGPI $124.96
  • Technical
  • Relative Strength Index (RSI)
  • CADL 45.08
  • MGPI 62.51
  • Support Level
  • CADL $5.75
  • MGPI $68.86
  • Resistance Level
  • CADL $7.34
  • MGPI $83.61
  • Average True Range (ATR)
  • CADL 0.50
  • MGPI 2.46
  • MACD
  • CADL 0.12
  • MGPI 0.99
  • Stochastic Oscillator
  • CADL 33.47
  • MGPI 73.83

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: